Shares of SRAD are plunging approximately 22% in Wednesday's session on April 22, 2026, declining from a prior close of $16.84 to approximately $13.13, as investors react to a combination of weaker-than-expected full-year 2025 financial results and a downward revision to the company's 2026 organic growth outlook.
The primary catalyst is the April 21 release of Sportradar's Q4 and full-year 2025 earnings, which showed revenue falling modestly short of analyst consensus estimates due to significant foreign exchange headwinds — an increasingly critical variable for the Swiss-headquartered company generating revenue across dozens of currencies.
2026 organic growth rate guidance was revised downward, reflecting ongoing concerns about currency conversion impacts and broader macroeconomic conditions that are weighing on the sports betting technology ecosystem.
Truist Securities lowered its price target on SRAD from $32 to $26 on April 21, maintaining a Buy rating — the third analyst target reduction in recent months — reinforcing a sustained narrative of earnings deceleration.
The stock has now declined approximately 58.7% from its 52-week high of $32.22, and Wednesday's selloff pushes SRAD toward its 52-week low of $14.70.
Traders will focus on the Q1 2026 earnings release scheduled for May 6, 2026, and whether management can demonstrate stabilization in FX-adjusted revenue trends.
Sportradar Group AG (SRAD) is a St. Gallen, Switzerland-based global sports technology company and the world's leading B2B provider of sports data, analytics, and technology platforms, serving the sports betting, media, and sports federation markets across more than 120 countries. The company collects, processes, and distributes real-time sports data — powering odds compilation, live streaming, integrity services, and fan engagement products for major customers including global sportsbooks, broadcasters, and leagues. Shares are declining approximately 22% on Wednesday, April 22, 2026, falling from a prior close of $16.84 to approximately $13.13 in heavy volume trading. The selloff is a direct earnings-driven market reaction to the company's Q4 and full-year 2025 results, released April 21, which missed consensus revenue estimates on foreign exchange headwinds and included a downward revision to the 2026 organic growth outlook.
The definitive catalyst for today's 22% price decline is the market's full post-earnings digestion of Sportradar's Q4 and full-year 2025 financial results, released after the close on April 21. Revenue came in modestly below analyst consensus estimates, with the shortfall attributed primarily to unfavorable foreign currency translation effects — a structural challenge for a company that generates a substantial portion of its revenue in euros, British pounds, and other non-dollar currencies but reports in USD. The 2026 organic growth rate guidance was revised downward from prior expectations, with management citing worsening currency conversion impacts and broader macroeconomic uncertainty as headwinds to the near-term top-line trajectory. For a stock that had already been heavily sold over the preceding 12 months — down 32.7% year-over-year — the absence of a positive earnings inflection point removes the key catalyst needed to stabilize investor confidence and triggers another leg of institutional selling.
The earnings-driven selloff is amplified by the sustained pattern of analyst price target reductions that has characterized SRAD coverage over the past several months. Truist Securities lowered its price target from $32 to $26 on April 21 while maintaining a Buy rating — a reduction of 18.75% in the target that signals declining earnings confidence even among the stock's most constructive institutional analysts. Morgan Stanley maintained an Equal-Weight rating with a $25 target, while Wells Fargo previously cut to $24 from $26 in early March 2026. The convergence of these target reductions toward the $24–$26 range — now well above today's trading level near $13 — reflects how quickly the earnings deceleration has outpaced analyst model revisions. With 19 Buy and 2 Hold ratings from 24 covering analysts, the formal institutional consensus remains constructive, but the gap between analyst targets and actual trading price is a persistent source of credibility pressure on those recommendations.
A recurring and structurally important driver of SRAD's earnings trajectory is the foreign exchange translation impact on its reported USD results. As a Swiss company operating across the European sports betting market — where a significant portion of customer contracts are denominated in euros and sterling — Sportradar is directly exposed to U.S. dollar strengthening. The dollar's appreciation against major currencies in the first quarter of 2026 translated to meaningful top-line compression when results are converted to USD for reporting. Combined with macroeconomic headwinds affecting consumer-facing sportsbook spending in key European markets, the FX impact has made it structurally difficult for Sportradar to beat USD-denominated revenue consensus estimates in the current rate environment. This dynamic is unlikely to resolve quickly, given that the Federal Reserve's rate path and the dollar's trajectory remain uncertain heading into the second half of 2026.
Volume in SRAD on April 22 is tracking substantially above its 30-day average of approximately 2.69 million shares, confirming a high-conviction institutional repositioning event. The iShares Expanded Tech-Software Sector ETF (IGV) and broader technology sector ETFs are under moderate pressure Wednesday, but SRAD's decline is dramatically larger than the sector average, confirming that the selloff is earnings-driven rather than macro-driven. Technically, SRAD has broken decisively below the $15.50 support level identified by multiple technical analysts and is now approaching the 52-week low of $14.70 — with today's trading near $13.13 representing a potential new 52-week low if sustained through the close. The stock's 200-day simple moving average sits well above current price levels, confirming an extended technical downtrend.
For traders navigating sharp earnings-driven selloffs in global sports technology stocks like today's decline in SRAD, Tickeron's Trending AI Robots page provides a curated view of the platform's strongest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers, but only those demonstrating the highest real-time performance are featured in this section. Bots span a wide range of strategy types, holding timeframes, risk profiles, performance metrics, and the universe of symbols they trade — from mean-reversion systems designed for post-earnings dislocations to longer-timeframe systematic strategies built for technology sector equities. Whether you are managing exposure following sharp earnings-driven price drops or identifying structured opportunities across the broader market, the Trending AI Robots page is a practical starting point for AI-assisted trading.
The next critical event for SRAD is the Q1 2026 earnings release on May 6, 2026, accompanied by a management webcast at 8:30 a.m. ET. This print will be the first opportunity for Sportradar's leadership team to address investor concerns about the 2026 organic growth deceleration, provide an updated FX sensitivity framework, and clarify the cadence of revenue recognition from new long-term contracts — including the company's expanded partnerships with the NBA, NFL, and major European football leagues. Investors will scrutinize whether the Q1 revenue growth rate on an FX-neutral basis is holding to management's projections and whether the $1 billion share buyback program announced in March 2026 will be deployed aggressively to support the stock at depressed levels. Key risks include further USD strengthening compressing reported revenues, slowing growth in U.S. online sports betting handle as market saturation increases in established states, competitive pressure from in-house data capabilities being developed by major sportsbooks, and the possibility of further analyst estimate reductions if Q1 2026 results disappoint.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SRAD declined for three days, in of 261 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on May 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRAD as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
SRAD moved below its 50-day moving average on April 17, 2026 date and that indicates a change from an upward trend to a downward trend.
The Aroon Indicator for SRAD entered a downward trend on May 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SRAD's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for SRAD just turned positive on May 07, 2026. Looking at past instances where SRAD's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRAD advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .
SRAD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.482) is normal, around the industry mean (22.334). P/E Ratio (48.047) is within average values for comparable stocks, (66.829). SRAD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.599). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (2.534) is also within normal values, averaging (57.284).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SRAD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware